CME Activity: Recent Updates on Anti-Amyloid Therapies for Early Alzheimer's Disease
Summary
A CME (Continuing Medical Education) activity scheduled for July 15, 2026, focusing on how recent updates are informing the use of anti-amyloid therapies in early Alzheimer's disease. The session is a 30-minute educational event aimed at healthcare professionals.
Source
Key quotes
· 2 pulledWednesday, July 15, 2026 | 1:30 pm - 2:00 pm ET
How Recent Updates Are Informing the Use of Anti-Amyloid Therapies in Early Alzheimer's Disease
You might also wanna read
https://doi.org/10.1126/science.aeb6987
Alzheimer's Research Impact: Uncovering a 16-Year Setback
A landmark study in Nature that identified a possible cause of Alzheimer’s disease in 2006 influenced research for almost 16 years until con
AI Speech Analysis Shows Promise for Early Cognitive Impairment Screening, Study Finds
A recent feasibility study published in JAMA Neurology tested machine learning algorithms that analyze conversational speech patterns to ide
Alzheimer's Disease Disrupts Circadian Rhythms in Brain Cells Responsible for Amyloid Clearance
A mouse study from Washington University School of Medicine reveals that Alzheimer's disease disrupts the circadian rhythms of brain cells r
London Summit explores AI-powered clinical trials for neurodegenerative diseases
The DEMON Network and LifeArc hosted the London Summit on AI Enabled Trials in Neurodegeneration on 27 May 2026, bringing together researche
dementiaresearcher.nihr.ac.uk·4d agoAlzheimer's Treatment Clears Brain Plaques in Mice Within Hours
Scientists have developed a treatment that repairs the brain's natural gateway system in mice with Alzheimer's-like conditions, allowing amy
Comments
Sign in to join the conversation.
No comments yet. Be the first.
